Dr. Gregor Fachinger
Merck KGaA
Symposia
It goes without saying that the pharmaceutical industry has a great interest and need in external innovation. After a period in which very early developments were also purchased or licensed, there is now a shift back to more mature projects. Business developers discuss how to strategically position partnering in the future.
Dr. Gregor Fachinger
Merck KGaA
Dr. Bernd Nosse
Boehringer Ingelheim
Dr. Uli Stilz
Novo Nordisk